MedPath

Coordinated Reset Deep Brain Stimulation

Not Applicable
Recruiting
Conditions
Parkinson's Disease (PD)
Interventions
Device: Novel Programming (nDBS)
Device: Conventional Programming (cDBS)
Registration Number
NCT03732898
Lead Sponsor
Boston Scientific Corporation
Brief Summary

The study will explore the viability of an alternative/novel programming strategy in Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD).

Detailed Description

The study will explore the feasibility of utilizing an alternative/novel programming technique in Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
14
Inclusion Criteria
  1. Subject with PD implanted bilaterally in the STN and receiving DBS therapy for at least 3 months.
  2. Tolerates > 12 hours OFF medication and, per clinical judgment, be able to perform all study related procedures.
  3. Able to understand the study requirements and the treatment procedures and must provide written informed consent before any study-specific tests or procedures are performed.

Key

Exclusion Criteria
  1. Exhibits significant psychiatric problems, including unrelated clinically significant depression as determined by the investigator.
  2. A female who is pregnant, is breastfeeding, or is of childbearing potential and planning to get pregnant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Novel Deep Brain Stimulation (nDBS) programNovel Programming (nDBS)This arm will include patients receiving stimulation with a novel Deep Brain Stimulation (nDBS) for Parkinson's Disease (PD).
Conventional Deep Brain Stimulation (cDBS) programConventional Programming (cDBS)This arm will include patients receiving stimulation with a conventional Deep Brain Stimulation (cDBS) for Parkinson's Disease (PD).
Primary Outcome Measures
NameTimeMethod
Improvement in Quality of Life using new programming paradigm: PDQ-39approximately 4 weeks

Change in Parkinson's Disease Questionnaire (PDQ-39) summary index and sub-scores

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University Berlin, Charite Virchow

🇩🇪

Berlin, Germany

Universitaetsklinikum Wuerzburg

🇩🇪

Wuerzburg, Germany

University Berlin, Charite Virchow
🇩🇪Berlin, Germany
Boston Scientific Clinical Research Manager
Contact
855-213-9890
BSNClinicalTrials@bsci.com
© Copyright 2025. All Rights Reserved by MedPath